Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Zhejiang Provincial People's Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Washington
Mayo Clinic
National Cancer Institute, Egypt
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
City of Hope Medical Center
City of Hope Medical Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Ohio State University Comprehensive Cancer Center
University of Turin, Italy
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Yale University
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
St. Jude Children's Research Hospital
Providence Health & Services
St. Jude Children's Research Hospital
Tongji Hospital
First Affiliated Hospital of Zhejiang University
The General Hospital of Western Theater Command
Stanford University
Memorial Sloan Kettering Cancer Center
University of Washington
Affiliated Hospital to Academy of Military Medical Sciences
University College, London
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Baylor College of Medicine
Roswell Park Cancer Institute
Baylor College of Medicine
Masonic Cancer Center, University of Minnesota
Hackensack Meridian Health
Dana-Farber Cancer Institute